About the study: There was no statistically significant difference in the rate of psychosis-related diagnoses or antipsychotics prescribed in states with medical or recreational cannabis policies compared to states without such policies in this study of commercial and Medicare Advantage claims data from 2003 to 2017. As states continue to introduce new Introducing cannabis policies, an ongoing evaluation of psychosis as a possible consequence of state legalization of cannabis may be informative.
Authors: Holly Elser, MD, Ph.D., of the University of Pennsylvania Hospital in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: See the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Embed this link to give your readers free access to the full-text article This link will be live during embargo http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.52689?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=012523
As regards JAMA network opened: JAMA network opened is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary on more than 40 medical and health topics. Every article is free online from the day of publication.
JAMA network opened
disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of information through the EurekAlert system.